 | • レポートコード：20QY06-01982 • 出版社/出版日：QYResearch / 2020年6月1日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、144ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医薬品・医療 |
| Single User | ￥592,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥888,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,184,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社の当調査資料では、シアノコバラミン注射のグローバル市場について種類別（ビタミン、サプリ）、用途別（病院、クリニック、その他）、地域別（北米、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。 ・シアノコバラミン注射市場の概要 ・世界の主要地域別シアノコバラミン注射市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界のシアノコバラミン注射市場規模2015-2026：種類別（ビタミン、サプリ） ・世界のシアノコバラミン注射市場規模2015-2026：用途別（病院、クリニック、その他） ・シアノコバラミン注射の北米市場規模2015-2020 ・シアノコバラミン注射のヨーロッパ市場規模2015-2020 ・シアノコバラミン注射の中国市場規模2015-2020 ・シアノコバラミン注射の日本市場規模2015-2020 ・シアノコバラミン注射の東南アジア市場規模2015-2020 ・シアノコバラミン注射のインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 （Luitpold Pharmaceuticals、Luitpold Pharmaceuticals (Daiichi Sankyo)、Endo International、Bristol-Myers Squibb、Sanofi-Aventis、Jamieson、Teva (Actavis)、Merck、Mylan、Bayer HealthCare、Pfizer、ANGELINI、Biological E、CCEPCD、Huaxin Pharmaceutical） ・シアノコバラミン注射の製造コスト分析 ・販売チャネル、流通業者、顧客 ・シアノコバラミン注射の市場動向・機会・課題 ・調査の結論 |
Cyanocobalamin is a man-made form of vitamin B12 used to prevent and treat low blood levels of this vitamin. Most people get enough vitamin B12 from their diet. Vitamin B12 is important to maintain the health of your metabolism, blood cells, and nerves.
Market Analysis and Insights: Global Cyanocobalamin Injection Market
The global Cyanocobalamin Injection market was valued at US$ xx million in 2019 and will reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2020-2026.
Global Cyanocobalamin Injection Scope and Market Size
The global Cyanocobalamin Injection market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Cyanocobalamin Injection market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Cyanocobalamin Injection market is segmented into
Vitamins
Supplements
Segment by Application, the Cyanocobalamin Injection market is segmented into
Hospitals
Clinics
Others
The Cyanocobalamin Injection market is analysed and market size information is provided by regions (countries). Segment by Application, the Cyanocobalamin Injection market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Cyanocobalamin Injection Market Share Analysis
Cyanocobalamin Injection market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Cyanocobalamin Injection business, the date to enter into the Cyanocobalamin Injection market, Cyanocobalamin Injection product introduction, recent developments, etc.
The major vendors covered:
Luitpold Pharmaceuticals
Luitpold Pharmaceuticals (Daiichi Sankyo)
Endo International
Bristol-Myers Squibb
Sanofi-Aventis
Jamieson
Teva (Actavis)
Merck
Mylan
Bayer HealthCare
Pfizer
ANGELINI
Biological E
CCEPCD
Huaxin Pharmaceutical
Table of Contents
1 Cyanocobalamin Injection Market Overview
1.1 Cyanocobalamin Injection Product Scope
1.2 Cyanocobalamin Injection Segment by Type
1.2.1 Global Cyanocobalamin Injection Sales by Type (2020-2026)
1.2.2 Vitamins
1.2.3 Supplements
1.3 Cyanocobalamin Injection Segment by Application
1.3.1 Global Cyanocobalamin Injection Sales Comparison by Application (2020-2026)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Cyanocobalamin Injection Market Estimates and Forecasts (2015-2026)
1.4.1 Global Cyanocobalamin Injection Sales Growth Rate (2015-2026)
1.4.2 Global Cyanocobalamin Injection Revenue and Growth Rate (2015-2026)
1.4.3 Global Cyanocobalamin Injection Price Trends (2015-2026)
2 Cyanocobalamin Injection Estimate and Forecast by Region
2.1 Global Cyanocobalamin Injection Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Cyanocobalamin Injection Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Cyanocobalamin Injection Sales Market Share by Region (2015-2020)
2.2.2 Global Cyanocobalamin Injection Revenue Market Share by Region (2015-2020)
2.3 Global Cyanocobalamin Injection Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Cyanocobalamin Injection Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Cyanocobalamin Injection Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Cyanocobalamin Injection Estimates and Projections (2015-2026)
2.4.2 Europe Cyanocobalamin Injection Estimates and Projections (2015-2026)
2.4.3 China Cyanocobalamin Injection Estimates and Projections (2015-2026)
2.4.4 Japan Cyanocobalamin Injection Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Cyanocobalamin Injection Estimates and Projections (2015-2026)
2.4.6 India Cyanocobalamin Injection Estimates and Projections (2015-2026)
3 Global Cyanocobalamin Injection Competition Landscape by Players
3.1 Global Top Cyanocobalamin Injection Players by Sales (2015-2020)
3.2 Global Top Cyanocobalamin Injection Players by Revenue (2015-2020)
3.3 Global Cyanocobalamin Injection Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cyanocobalamin Injection as of 2019)
3.4 Global Cyanocobalamin Injection Average Price by Company (2015-2020)
3.5 Manufacturers Cyanocobalamin Injection Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Cyanocobalamin Injection Players (Opinion Leaders)
4 Global Cyanocobalamin Injection Market Size by Type
4.1 Global Cyanocobalamin Injection Historic Market Review by Type (2015-2020)
4.1.1 Global Cyanocobalamin Injection Sales Market Share by Type (2015-2020)
4.1.2 Global Cyanocobalamin Injection Revenue Market Share by Type (2015-2020)
4.1.3 Global Cyanocobalamin Injection Price by Type (2014-2020)
4.2 Global Cyanocobalamin Injection Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Cyanocobalamin Injection Sales Forecast by Type (2021-2026)
4.2.2 Global Cyanocobalamin Injection Revenue Forecast by Type (2021-2026)
4.2.3 Global Cyanocobalamin Injection Price Forecast by Type (2021-2026)
5 Global Cyanocobalamin Injection Market Size by Application
5.1 Global Cyanocobalamin Injection Historic Market Review by Application (2015-2020)
5.1.1 Global Cyanocobalamin Injection Sales Market Share by Application (2015-2020)
5.1.2 Global Cyanocobalamin Injection Revenue Market Share by Application (2015-2020)
5.1.3 Global Cyanocobalamin Injection Price by Application (2015-2020)
5.2 Global Cyanocobalamin Injection Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Cyanocobalamin Injection Sales Forecast by Application (2021-2026)
5.2.2 Global Cyanocobalamin Injection Revenue Forecast by Application (2021-2026)
5.2.3 Global Cyanocobalamin Injection Price Forecast by Application (2021-2026)
3 North America Cyanocobalamin Injection Market Facts & Figures
3.2 North America Cyanocobalamin Injection Sales Market Share by Company (2015-2020)
3.3 North America Cyanocobalamin Injection Sales Market Share by Type (2015-2020)
3.4 North America Cyanocobalamin Injection Sales Market Share by Application (2015-2020)
4 Europe Cyanocobalamin Injection Market Facts & Figures
4.2 Europe Cyanocobalamin Injection Sales Market Share by Company (2015-2020)
4.3 Europe Cyanocobalamin Injection Sales Market Share by Type (2015-2020)
4.4 Europe Cyanocobalamin Injection Sales Market Share by Application (2015-2020)
5 China Cyanocobalamin Injection Market Facts & Figures
5.2 China Cyanocobalamin Injection Sales Market Share by Company (2015-2020)
5.3 China Cyanocobalamin Injection Sales Market Share by Type (2015-2020)
5.4 China Cyanocobalamin Injection Sales Market Share by Application (2015-2020)
6 Japan Cyanocobalamin Injection Market Facts & Figures
6.2 Japan Cyanocobalamin Injection Sales Market Share by Company (2015-2020)
6.3 Japan Cyanocobalamin Injection Sales Market Share by Type (2015-2020)
6.4 Japan Cyanocobalamin Injection Sales Market Share by Application (2015-2020)
7 Southeast Asia Cyanocobalamin Injection Market Facts & Figures
7.2 Southeast Asia Cyanocobalamin Injection Sales Market Share by Company (2015-2020)
7.3 Southeast Asia Cyanocobalamin Injection Sales Market Share by Type (2015-2020)
7.4 Southeast Asia Cyanocobalamin Injection Sales Market Share by Application (2015-2020)
8 India Cyanocobalamin Injection Market Facts & Figures
8.2 India Cyanocobalamin Injection Sales Market Share by Company (2015-2020)
8.3 India Cyanocobalamin Injection Sales Market Share by Type (2015-2020)
8.4 India Cyanocobalamin Injection Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in Cyanocobalamin Injection Business
12.1 Luitpold Pharmaceuticals
12.1.1 Luitpold Pharmaceuticals Cyanocobalamin Injection Corporation Information
12.1.2 Luitpold Pharmaceuticals Cyanocobalamin Injection Business Overview and Total Revenue
12.1.3 Luitpold Pharmaceuticals Cyanocobalamin Injection Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Luitpold Pharmaceuticals Cyanocobalamin Injection Products Offered
12.1.5 Luitpold Pharmaceuticals Recent Development
12.2 Luitpold Pharmaceuticals (Daiichi Sankyo)
12.2.1 Luitpold Pharmaceuticals (Daiichi Sankyo) Cyanocobalamin Injection Corporation Information
12.2.2 Luitpold Pharmaceuticals (Daiichi Sankyo) Cyanocobalamin Injection Business Overview and Total Revenue
12.2.3 Luitpold Pharmaceuticals (Daiichi Sankyo) Cyanocobalamin Injection Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Luitpold Pharmaceuticals (Daiichi Sankyo) Cyanocobalamin Injection Products Offered
12.2.5 Luitpold Pharmaceuticals (Daiichi Sankyo) Recent Development
12.3 Endo International
12.3.1 Endo International Cyanocobalamin Injection Corporation Information
12.3.2 Endo International Cyanocobalamin Injection Business Overview and Total Revenue
12.3.3 Endo International Cyanocobalamin Injection Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Endo International Cyanocobalamin Injection Products Offered
12.3.5 Endo International Recent Development
12.4 Bristol-Myers Squibb
12.4.1 Bristol-Myers Squibb Cyanocobalamin Injection Corporation Information
12.4.2 Bristol-Myers Squibb Cyanocobalamin Injection Business Overview and Total Revenue
12.4.3 Bristol-Myers Squibb Cyanocobalamin Injection Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Bristol-Myers Squibb Cyanocobalamin Injection Products Offered
12.4.5 Bristol-Myers Squibb Recent Development
12.5 Sanofi-Aventis
12.5.1 Sanofi-Aventis Cyanocobalamin Injection Corporation Information
12.5.2 Sanofi-Aventis Cyanocobalamin Injection Business Overview and Total Revenue
12.5.3 Sanofi-Aventis Cyanocobalamin Injection Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Sanofi-Aventis Cyanocobalamin Injection Products Offered
12.5.5 Sanofi-Aventis Recent Development
12.6 Jamieson
12.6.1 Jamieson Cyanocobalamin Injection Corporation Information
12.6.2 Jamieson Cyanocobalamin Injection Business Overview and Total Revenue
12.6.3 Jamieson Cyanocobalamin Injection Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Jamieson Cyanocobalamin Injection Products Offered
12.6.5 Jamieson Recent Development
12.7 Teva (Actavis)
12.7.1 Teva (Actavis) Cyanocobalamin Injection Corporation Information
12.7.2 Teva (Actavis) Cyanocobalamin Injection Business Overview and Total Revenue
12.7.3 Teva (Actavis) Cyanocobalamin Injection Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Teva (Actavis) Cyanocobalamin Injection Products Offered
12.7.5 Teva (Actavis) Recent Development
12.8 Merck
12.8.1 Merck Cyanocobalamin Injection Corporation Information
12.8.2 Merck Cyanocobalamin Injection Business Overview and Total Revenue
12.8.3 Merck Cyanocobalamin Injection Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Merck Cyanocobalamin Injection Products Offered
12.8.5 Merck Recent Development
12.9 Mylan
12.9.1 Mylan Cyanocobalamin Injection Corporation Information
12.9.2 Mylan Cyanocobalamin Injection Business Overview and Total Revenue
12.9.3 Mylan Cyanocobalamin Injection Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Mylan Cyanocobalamin Injection Products Offered
12.9.5 Mylan Recent Development
12.10 Bayer HealthCare
12.10.1 Bayer HealthCare Cyanocobalamin Injection Corporation Information
12.10.2 Bayer HealthCare Cyanocobalamin Injection Business Overview and Total Revenue
12.10.3 Bayer HealthCare Cyanocobalamin Injection Sales, Revenue and Gross Margin (2015-2020)
12.10.4 Bayer HealthCare Cyanocobalamin Injection Products Offered
12.10.5 Bayer HealthCare Recent Development
12.11 Pfizer
12.11.1 Pfizer Cyanocobalamin Injection Corporation Information
12.11.2 Pfizer Cyanocobalamin Injection Business Overview and Total Revenue
12.11.3 Pfizer Cyanocobalamin Injection Sales, Revenue and Gross Margin (2015-2020)
12.11.4 Pfizer Cyanocobalamin Injection Products Offered
12.11.5 Pfizer Recent Development
12.12 ANGELINI
12.12.1 ANGELINI Cyanocobalamin Injection Corporation Information
12.12.2 ANGELINI Cyanocobalamin Injection Business Overview and Total Revenue
12.12.3 ANGELINI Cyanocobalamin Injection Sales, Revenue and Gross Margin (2015-2020)
12.12.4 ANGELINI Cyanocobalamin Injection Products Offered
12.12.5 ANGELINI Recent Development
12.13 Biological E
12.13.1 Biological E Cyanocobalamin Injection Corporation Information
12.13.2 Biological E Cyanocobalamin Injection Business Overview and Total Revenue
12.13.3 Biological E Cyanocobalamin Injection Sales, Revenue and Gross Margin (2015-2020)
12.13.4 Biological E Cyanocobalamin Injection Products Offered
12.13.5 Biological E Recent Development
12.14 CCEPCD
12.14.1 CCEPCD Cyanocobalamin Injection Corporation Information
12.14.2 CCEPCD Cyanocobalamin Injection Business Overview and Total Revenue
12.14.3 CCEPCD Cyanocobalamin Injection Sales, Revenue and Gross Margin (2015-2020)
12.14.4 CCEPCD Cyanocobalamin Injection Products Offered
12.14.5 CCEPCD Recent Development
12.15 Huaxin Pharmaceutical
12.15.1 Huaxin Pharmaceutical Cyanocobalamin Injection Corporation Information
12.15.2 Huaxin Pharmaceutical Cyanocobalamin Injection Business Overview and Total Revenue
12.15.3 Huaxin Pharmaceutical Cyanocobalamin Injection Sales, Revenue and Gross Margin (2015-2020)
12.15.4 Huaxin Pharmaceutical Cyanocobalamin Injection Products Offered
12.15.5 Huaxin Pharmaceutical Recent Development
13 Cyanocobalamin Injection Manufacturing Cost Analysis
13.1 Cyanocobalamin Injection Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Cyanocobalamin Injection
13.4 Cyanocobalamin Injection Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Cyanocobalamin Injection Distributors List
14.3 Cyanocobalamin Injection Customers
15 Market Dynamics
15.1 Market Trends
15.2 Opportunities and Drivers
15.3 Challenges
15.4 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Cyanocobalamin Injection Sales (K Doses) Growth Rate by Type (2020-2026)
Table 2. Global Cyanocobalamin Injection Sales (K Doses) Comparison by Application (2020-2026)
Table 3. Global Market Cyanocobalamin Injection Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 4. Global Cyanocobalamin Injection Sales (K Doses) by Region (2015-2020)
Table 5. Global Cyanocobalamin Injection Sales Market Share by Region (2015-2020)
Table 6. Global Cyanocobalamin Injection Revenue (US$ Million) Market Share by Region (2015-2020))
Table 7. Global Cyanocobalamin Injection Revenue Share by Region (2015-2020)
Table 8. Global Cyanocobalamin Injection Sales (K Doses) Forecast by Region (2021-2026)
Table 9. Global Cyanocobalamin Injection Sales Market Share Forecast by Region (2021-2026)
Table 10. Global Cyanocobalamin Injection Revenue (US$ Million) Forecast by Region (2021-2026)
Table 11. Global Cyanocobalamin Injection Revenue Share Forecast by Region (2021-2026)
Table 12. Global Cyanocobalamin Injection (K Doses) of Key Companies (2015-2020)
Table 13. Global Cyanocobalamin Injection Sales Share by Company (2015-2020)
Table 14. Global Cyanocobalamin Injection Revenue (US$ Million) by Company (2015-2020)
Table 15. Global Cyanocobalamin Injection Revenue Share by Company (2015-2020)
Table 16. Global Cyanocobalamin Injection by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cyanocobalamin Injection as of 2019)
Table 17. Global Cyanocobalamin Injection Average Price (USD/Dose) of Key Company (2015-2020)
Table 18. Manufacturers Cyanocobalamin Injection Manufacturing Sites and Area Served
Table 19. Manufacturers Cyanocobalamin Injection Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Main Points Interviewed from Key Cyanocobalamin Injection Players
Table 22. Global Cyanocobalamin Injection Sales (K Doses) by Type (2015-2020)
Table 23. Global Cyanocobalamin Injection Sales Share by Type (2015-2020)
Table 24. Global Cyanocobalamin Injection Revenue (US$ Million) Market Share by Type (2015-2020)
Table 25. Global Cyanocobalamin Injection Price (K Doses) by Type (2015-2020)
Table 26. Global Cyanocobalamin Injection Sales Share by Type (2021-2026)
Table 27. Global Cyanocobalamin Injection Revenue (US$ Million) Market Share by Type (2021-2026)
Table 28. Global Cyanocobalamin Injection Revenue Share by Type (2021-2026)
Table 29. Global Cyanocobalamin Injection Price (K Doses) by Type (2021-2026)
Table 30. Global Cyanocobalamin Injection Sales (K Doses) by Application (2015-2020)
Table 31. Global Cyanocobalamin Injection Sales Share by Application (2015-2020)
Table 32. Global Cyanocobalamin Injection Revenue (US$ Million) Market Share by Application (2015-2020)
Table 33. Global Cyanocobalamin Injection Price (K Doses) by Application (2015-2020)
Table 34. Global Cyanocobalamin Injection Sales (K Doses) by Application (2021-2026)
Table 35. Global Cyanocobalamin Injection Sales Share by Application (2021-2026)
Table 36. Global Cyanocobalamin Injection Revenue (US$ Million) Market Share by Application (2021-2026)
Table 37. Global Cyanocobalamin Injection Revenue Share by Application (2021-2026)
Table 38. Global Cyanocobalamin Injection Price (K Doses) by Application (2021-2026)
Table 39. United States Cyanocobalamin Injection Sales (K Doses) by Company (2015-2020)
Table 40. United States Cyanocobalamin Injection Sales Market Share by Company (2015-2020)
Table 41. United States Cyanocobalamin Injection Sales (K Doses) by Type (2015-2020)
Table 42. United States Cyanocobalamin Injection Sales Market Share by Type (2015-2020)
Table 43. United States Cyanocobalamin Injection Sales (K Doses) by Application (2015-2020)
Table 44. United States Cyanocobalamin Injection Sales Market Share by Application (2015-2020)
Table 45. Europe Cyanocobalamin Injection Sales (K Doses) by Company (2015-2020)
Table 46. Europe Cyanocobalamin Injection Sales Market Share by Company (2015-2020)
Table 47. Europe Cyanocobalamin Injection Sales (K Doses) by Type (2015-2020)
Table 48. Europe Cyanocobalamin Injection Sales Market Share by Type (2015-2020)
Table 49. Europe Cyanocobalamin Injection Sales (K Doses) by Application (2015-2020)
Table 50. Europe Cyanocobalamin Injection Sales Market Share by Type (2015-2020)
Table 51. China Cyanocobalamin Injection Sales (K Doses) by Company (2015-2020)
Table 52. China Cyanocobalamin Injection Sales Market Share by Company (2015-2020)
Table 53. China Cyanocobalamin Injection Sales (K Doses) by Type (2015-2020)
Table 54. China Cyanocobalamin Injection Sales Market Share by Type (2015-2020)
Table 55. China Cyanocobalamin Injection Sales (K Doses) by Application (2015-2020)
Table 56. China Cyanocobalamin Injection Sales Market Share by Application (2015-2020)
Table 57. Japan Cyanocobalamin Injection Sales (K Doses) by Company (2015-2020)
Table 58. Japan Cyanocobalamin Injection Sales Market Share by Company (2015-2020)
Table 59. Japan Cyanocobalamin Injection Sales (K Doses) by Type (2015-2020)
Table 60. Japan Cyanocobalamin Injection Sales Market Share by Type (2015-2020)
Table 61. Japan Cyanocobalamin Injection Sales (K Doses) by Application (2015-2020)
Table 62. Japan Cyanocobalamin Injection Sales Market Share by Application (2015-2020)
Table 63. Southeast Asia Cyanocobalamin Injection Sales (K Doses) by Company (2015-2020)
Table 64. Southeast Asia Cyanocobalamin Injection Sales Market Share by Company (2015-2020)
Table 65. Southeast Asia Cyanocobalamin Injection Sales (K Doses) by Type (2015-2020)
Table 66. Southeast Asia Cyanocobalamin Injection Sales Market Share by Type (2015-2020)
Table 67. Southeast Asia Cyanocobalamin Injection Sales (K Doses) by Type (2015-2020)
Table 68. Southeast Asia Cyanocobalamin Injection Sales Market Share by Application (2015-2020)
Table 69. India Cyanocobalamin Injection Sales (K Doses) by Company (2015-2020)
Table 70. India Cyanocobalamin Injection Sales Market Share by Company (2015-2020)
Table 71. India Cyanocobalamin Injection Sales (K Doses) by Type (2015-2020)
Table 72. India Cyanocobalamin Injection Sales Market Share by Type (2015-2020)
Table 73. India Cyanocobalamin Injection Sales (K Doses) by Application (2015-2020)
Table 74. India Cyanocobalamin Injection Sales Market Share by Application (2015-2020)
Table 75. Luitpold Pharmaceuticals Corporation Information
Table 76. Luitpold Pharmaceuticals Description and Business Overview
Table 77. Luitpold Pharmaceuticals Cyanocobalamin Injection Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 78. Luitpold Pharmaceuticals Cyanocobalamin Injection Product
Table 79. Luitpold Pharmaceuticals Recent Development
Table 80. Luitpold Pharmaceuticals (Daiichi Sankyo) Corporation Information
Table 81. Luitpold Pharmaceuticals (Daiichi Sankyo) Description and Business Overview
Table 82. Luitpold Pharmaceuticals (Daiichi Sankyo) Cyanocobalamin Injection Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 83. Luitpold Pharmaceuticals (Daiichi Sankyo) Cyanocobalamin Injection Product
Table 84. Luitpold Pharmaceuticals (Daiichi Sankyo) Recent Development
Table 85. Endo International Corporation Information
Table 86. Endo International Description and Business Overview
Table 87. Endo International Cyanocobalamin Injection Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 88. Endo International Cyanocobalamin Injection Product
Table 89. Endo International Recent Development
Table 90. Bristol-Myers Squibb Corporation Information
Table 91. Bristol-Myers Squibb Description and Business Overview
Table 92. Bristol-Myers Squibb Cyanocobalamin Injection Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 93. Bristol-Myers Squibb Cyanocobalamin Injection Product
Table 94. Bristol-Myers Squibb Recent Development
Table 95. Sanofi-Aventis Corporation Information
Table 96. Sanofi-Aventis Description and Business Overview
Table 97. Sanofi-Aventis Cyanocobalamin Injection Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 98. Sanofi-Aventis Cyanocobalamin Injection Product
Table 99. Sanofi-Aventis Recent Development
Table 100. Jamieson Corporation Information
Table 101. Jamieson Description and Business Overview
Table 102. Jamieson Cyanocobalamin Injection Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 103. Jamieson Cyanocobalamin Injection Product
Table 104. Jamieson Recent Development
Table 105. Teva (Actavis) Corporation Information
Table 106. Teva (Actavis) Description and Business Overview
Table 107. Teva (Actavis) Cyanocobalamin Injection Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 108. Teva (Actavis) Cyanocobalamin Injection Product
Table 109. Teva (Actavis) Recent Development
Table 110. Merck Corporation Information
Table 111. Merck Cyanocobalamin Injection Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 112. Merck Description and Business Overview
Table 113. Merck Cyanocobalamin Injection Product
Table 114. Merck Recent Development
Table 115. Mylan Corporation Information
Table 116. Mylan Cyanocobalamin Injection Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 117. Mylan Description and Business Overview
Table 118. Mylan Cyanocobalamin Injection Product
Table 119. Mylan Recent Development
Table 120. Bayer HealthCare Corporation Information
Table 121. Bayer HealthCare Description and Business Overview
Table 122. Bayer HealthCare Cyanocobalamin Injection Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 123. Bayer HealthCare Cyanocobalamin Injection Product
Table 124. Bayer HealthCare Recent Development
Table 125. Pfizer Corporation Information
Table 126. Pfizer Description and Business Overview
Table 127. Pfizer Cyanocobalamin Injection Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 128. Pfizer Cyanocobalamin Injection Product
Table 129. Pfizer Recent Development
Table 130. ANGELINI Corporation Information
Table 131. ANGELINI Description and Business Overview
Table 132. ANGELINI Cyanocobalamin Injection Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 133. ANGELINI Cyanocobalamin Injection Product
Table 134. ANGELINI Recent Development
Table 135. Biological E Corporation Information
Table 136. Biological E Description and Business Overview
Table 137. Biological E Cyanocobalamin Injection Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 138. Biological E Cyanocobalamin Injection Product
Table 139. Biological E Recent Development
Table 140. CCEPCD Corporation Information
Table 141. CCEPCD Description and Business Overview
Table 142. CCEPCD Cyanocobalamin Injection Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 143. CCEPCD Cyanocobalamin Injection Product
Table 144. CCEPCD Recent Development
Table 145. Huaxin Pharmaceutical Corporation Information
Table 146. Huaxin Pharmaceutical Description and Business Overview
Table 147. Huaxin Pharmaceutical Cyanocobalamin Injection Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 148. Huaxin Pharmaceutical Cyanocobalamin Injection Product
Table 149. Huaxin Pharmaceutical Recent Development
Table 150. Production Base and Market Concentration Rate of Raw Material
Table 151. Key Suppliers of Raw Materials
Table 152. Cyanocobalamin Injection Distributors List
Table 153. Cyanocobalamin Injection Customers List
Table 154. Market Key Trends
Table 155. Key Opportunities and Drivers: Impact Analysis (2020-2026)
Table 156. Key Challenges
Table 157. Research Programs/Design for This Report
Table 158. Key Data Information from Secondary Sources
Table 159. Key Data Information from Primary Sources
List of Figures
Figure 1. Cyanocobalamin Injection Product Picture
Figure 2. Global Cyanocobalamin Injection Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Cyanocobalamin Injection Market Share by Application in 2020 & 2026
Figure 6. Hospitals Examples
Figure 7. Clinics Examples
Figure 8. Others Examples
Figure 9. Global Cyanocobalamin Injection Sales (K Doses) Growth Rate (2015-2026)
Figure 10. Global Cyanocobalamin Injection Revenue (US$ Million) Growth Rate (2015-2026)
Figure 11. Global Cyanocobalamin Injection Price Trends Growth Rate (2015-2026) (USD/Dose)
Figure 12. Global Cyanocobalamin Injection Revenue Market Share by Region: 2015 VS 2020
Figure 13. Global Cyanocobalamin Injection Revenue Market Share by Region: 2021 VS 2026
Figure 14. United States Cyanocobalamin Injection Revenue (Million USD) Growth Rate (2015-2026)
Figure 15. United States Cyanocobalamin Injection Sales (K Doses) Growth Rate (2015-2026)
Figure 16. Europe Cyanocobalamin Injection Revenue (Million USD) Growth Rate (2015-2026)
Figure 17. Europe Cyanocobalamin Injection Sales (Million USD) Growth Rate (2015-2026)
Figure 18. China Cyanocobalamin Injection Revenue (Million USD) Growth Rate (2015-2026)
Figure 19. China Cyanocobalamin Injection Sales (Million USD) and Growth Rate (2015-2026)
Figure 20. Japan Cyanocobalamin Injection Revenue (Million USD) Growth Rate (2015-2026)
Figure 21. Japan Cyanocobalamin Injection Sales (Million USD) Growth Rate (2015-2026)
Figure 22. Southeast Asia Cyanocobalamin Injection Revenue (Million USD) Growth Rate (2015-2026)
Figure 23. Southeast Asia Cyanocobalamin Injection Sales (Million USD) Growth Rate (2015-2026)
Figure 24. India Cyanocobalamin Injection Revenue (Million USD) Growth Rate (2015-2026)
Figure 25. India Cyanocobalamin Injection Sales (Million USD) Growth Rate (2015-2026)
Figure 26. Global 5 Largest Cyanocobalamin Injection Players Market Share by Revenue in Cyanocobalamin Injection 2015 & 2019
Figure 27. Cyanocobalamin Injection Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 28. Global Cyanocobalamin Injection Revenue Share by Type (2015-2020)
Figure 29. Global Cyanocobalamin Injection Revenue Growth Rate by Type in 2015 & 2019
Figure 30. Global Cyanocobalamin Injection Revenue Share by Application (2015-2020)
Figure 31. Global Cyanocobalamin Injection Revenue Growth Rate by Application in 2015 & 2019
Figure 32. United States Cyanocobalamin Injection Sales Market Share by Type in 2019
Figure 33. United States Cyanocobalamin Injection Sales Market Share by Type in 2019
Figure 34. Europe Cyanocobalamin Injection Sales Market Share by Company in 2019
Figure 35. Europe Cyanocobalamin Injection Sales Market Share by Type in 2019
Figure 36. Europe Cyanocobalamin Injection Sales Market Share by Application in 2019
Figure 37. China Cyanocobalamin Injection Sales Market Share by Company in 2019
Figure 38. China Cyanocobalamin Injection Sales Market Share by Type in 2019
Figure 39. China Cyanocobalamin Injection Sales Market Share by Application in 2019
Figure 40. Japan Cyanocobalamin Injection Sales Market Share by Company in 2019
Figure 41. Japan Cyanocobalamin Injection Sales Market Share by Type in 2019
Figure 42. Japan Cyanocobalamin Injection Sales Market Share by Application in 2019
Figure 43. Southeast Asia Cyanocobalamin Injection Sales Market Share by Company in 2019
Figure 44. Southeast Asia Cyanocobalamin Injection Sales Market Share by Type in 2019
Figure 45. Southeast Asia Cyanocobalamin Injection Sales Market Share by Application in 2019
Figure 46. India Cyanocobalamin Injection Sales Market Share by Company in 2019
Figure 47. India Cyanocobalamin Injection Sales Market Share by Type in 2019
Figure 48. India Cyanocobalamin Injection Sales Market Share by Application in 2019
Figure 49. Luitpold Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 50. Luitpold Pharmaceuticals (Daiichi Sankyo) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 51. Endo International Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. Bristol-Myers Squibb Total Revenue (US$ Million): 2019 Compared with 2018
Figure 53. Sanofi-Aventis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. Jamieson Total Revenue (US$ Million): 2019 Compared with 2018
Figure 55. Teva (Actavis) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 56. Merck Total Revenue (US$ Million): 2019 Compared with 2018
Figure 57. Mylan Total Revenue (US$ Million): 2019 Compared with 2018
Figure 58. Bayer HealthCare Total Revenue (US$ Million): 2019 Compared with 2018
Figure 59. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 60. ANGELINI Total Revenue (US$ Million): 2019 Compared with 2018
Figure 61. Biological E Total Revenue (US$ Million): 2019 Compared with 2018
Figure 62. CCEPCD Total Revenue (US$ Million): 2019 Compared with 2018
Figure 63. Huaxin Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 64. Key Raw Materials Price Trend
Figure 65. Manufacturing Cost Structure of Cyanocobalamin Injection
Figure 66. Manufacturing Process Analysis of Cyanocobalamin Injection
Figure 67. Cyanocobalamin Injection Industrial Chain Analysis
Figure 68. Channels of Distribution
Figure 69. Distributors Profiles
Figure 70. Porter's Five Forces Analysis
Figure 71. Bottom-up and Top-down Approaches for This Report
Figure 72. Data Triangulation
Figure 73. Key Executives Interviewed
シアノコバラミンスプレーの世界市場レポート2020 Cyanocobalamin is a man-made form of vitamin B12 used to prevent and treat low blood levels of this vitamin. Most people get enough vitamin B12 from their diet. Vitamin B12 is important to maintain the health of your metabolism, blood cells, and nerves. Market Analysis and Insights: Global Cyanocoba…- シアノコバラミンの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Cyanocobalamin market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Cyanocobalamin market report p…
- ビタミンB12（シアノコバラミン）の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Vitamin B12 (Cyanocobalamin) market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Vitamin B12 (Cya…
- 注射用ミカファンギンナトリウムの世界市場レポート2020 Micafungin (trade name Mycamine) is an echinocandin antifungal drug used to treat and prevent invasive fungal infections including candidemia, abscesses and esophageal candidiasis. It inhibits the production of beta-1,3-glucan, an essential component of fungal cell walls. Micafungin is administered …
- 注射用マムシ由来凝血促進剤の世界市場レポート2020 Market Analysis and Insights: Global Haemocoagulase Agkistrodon for Injection Market The global Haemocoagulase Agkistrodon for Injection market was valued at US$ xx million in 2019 and will reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2020-2026. Global Haemocoagulase Agki…